Aβ accumulation

Biomarker

2 papers2 findings

  • Humans1
  • Animals1

Interventions

1

Nicotinamide mononucleotide

downin mice1

1 study
  1. Nicotinamide mononucleotide decreases Aβ accumulation in mice.

    “NMN supplementation also enhanced ATP production, mitochondrial function, and synaptic density in the hippocampus while reducing oxidative stress and Aβ accumulation in the brain.”

    AnimalsAPP/PS1 transgenic Alzheimer's disease modelbrain

    Nicotinamide mononucleotide supplementation modulates gut microbiota and metabolites to mitigate Alzheimer's disease pathology in APP/PS1 mice

    Journal of Alzheimer's disease : JAD10 Mar 2026

More on Nicotinamide mononucleotide

Associations

1

Aβ42/Aβ40

downin humans1

1 study
  1. Aβ42/Aβ40 is associated with Aβ accumulation in humans (b=-142.29, p=0.002).

    “plasma Aβ42/40 was significantly associated with Aβ accumulation (ADNI: b=‐142.29, p = 0.002; UPitt: b=‐0.27, p = 0.02)”

    HumansPET A- non-demented participants

    Utilization of plasma Aβ and p ‐tau217 in predicting Aβ accumulation in PET A‐ non‐demented participants

    AAIC 2025 abstract11 Jan 2026

More on Aβ42/Aβ40

Latest

Nov 2025: 0Dec 2025: 24Jan 2026: 7Feb 2026: 1Mar 2026: 2Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 4Sep 2026: 1Oct 2026: 241 in 12 months